Max Healthcare seeks acquisitions in proven territories with a 20-25% ROCE within 4-5 years for organic growth strategy.

Dr Agarwal IPO opened for subscription on January 29 and will end today, January 31 The IPO price band is set at ₹382 to ₹402 ...

Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025 ...

The ACA marketplace at HealthCare.gov is a great way to find health insurance if you can’t get coverage through work. Our ratings take into account a product's cost, features, ease of use ...

Shares of Cigna Group slid after the health insurer warned that higher health-care costs in one insurance unit weighed on profitability. Insurers saw profit margins soar in the pandemic as insurees ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...

Alterity Therapeutics ATHE shares moved upwards by 95.9% to $5.7 during Thursday's pre-market session. The market value of their outstanding shares is at $49.8 million. T ...

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where UnitedHealth Group Incorporated ...

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...